Alendronate sodium

Alendronate sodium

Products
Alendronate sodium
Alendronate sodium

Information

Therapeutic Area: Musculo-skeletal systemEU DMF availableUS DMF no. 16962 availableJapanese DMF availableCEP available Indication: Alendronate sodium is a bisphosphonate drug used for osteoporosis and several other bone diseasesMusculo-skeletal diseases
Main Categories
APIs (Active Pharmaceutical Ingredients)
All Categories
APIs (Active Pharmaceutical Ingredients)
Distribution areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)
Supplied from
Poland
Polpharma SAPolpharma Group is a high quality European pharma manufacturer and a reputable business partner for companies worldwide at every stage of product development, manufacturing & commercialization (FDF, API, CDMO, CMO). Polpharma API is a Poland-based CDMO of APIs, and significant European API producer, delivering products to more than 65 countries on 6 continents. We run with $45-million manufacturing expansion to include HPAPI and cryogenic technologies and investments in a pilot plant and R&D capabilities.

Log in

See all the content and easy-to-use features by logging in or registering!